← All causality assessments
Causality assessment · Expected pharmacological effect

Oxycodone Hydrochloride and Drug Dependence: is the FAERS signal real?

n=100,436 co-reports · PRR 158.4 · ROR 295.3
A written Bradford Hill assessment of one drug–event pair. The grade is a judgement about the signal, not a statement that this drug causes this event in any one person; FAERS counts are reports, not rates.
Expected pharmacological effect

Oxycodone Hydrochloride ↔ Drug Dependence

n=100,436 co-reports · PRR 158.4 · ROR 295.3

Oxycodone is a semi-synthetic mu-opioid agonist whose association with drug dependence is among the best-documented causal relationships in pharmacology: re-exposure produces euphoria, tolerance drives escalating use, and withdrawal upon cessation is clinically recognised. The FAERS data show 100,436 co-reports (PRR 158.4), reflecting both genuine addiction and the drug’s extraordinarily wide prescribing volume. The label’s boxed warning on addiction, abuse, and misuse directly mirrors the Hill criteria for causality.

Boxed warning: oxycodone label (addiction/abuse/misuse). CDC mortality reports; Johnson et al., JAMA 2018, PMID: 29538756.

Bradford Hill viewpointStatusNote
Temporality (necessary)metDocumented in regulatory label
StrengthmetPRR 158.4 with 100,436 co-reports
ConsistencymetReproduced across independent population cohorts
SpecificitypartialSpecific to mu-opioid class
Biological gradientmetDose escalation and tolerance documented
PlausibilitymetKnown mu-opioid receptor pharmacology
CoherencemetWithdrawal syndrome standard of care
Experimentn/aUnethical to randomise to addiction
AnalogymetOther mu-opioid agonists show identical patterns

This table is this page's own qualitative read of the literature cited above, not an automated or citation-gated assessment — see the note at the bottom of this page.

✗ No ClinicalTrials.gov results-posting trial in the top search hits for Oxycodone captured drug dependence as a tracked adverse event in a usable structure. Trials assess acute analgesia over days; dependence requires longer exposure. Drug-dependence is not a pre-specified AE endpoint in posted trial results.